BEGIN:VCALENDAR VERSION:2.0 PRODID:-//hacksw/handcal//NONSGML v1.0//EN BEGIN:VEVENT UID:9b641dd91300ddbade0ba63314f03307 DTSTAMP:20260517T120151Z DTSTART:20241014T140000 DTEND:20241014T153000 SUMMARY:WHS - Driving Action: Innovation and Access for a Resilient Response Against AMR DESCRIPTION:\nPD 10 – Driving Action: Innovation and Access for a Resilient Response Against AMR\nExploring Future Scenarios and Shaping Better Solutions\nOct. 14, 2024, CEST: 02:00 PM - 03:30 PM / UTC: 12:00 PM - 01:30 PM\n\n \nDigital Session: https://www.youtube.com/watch?v=_NqZhqOVU68\n \n\nPanel Discussion (PD 10) - Europe\n2024 is a significant year for addressing the urgency of Antimicrobial Resistance (AMR), which requires a broad, multi-stakeholder approach. Alarming statistics underpin the need for prompt action. In 2019, AMR was responsible for 1.27 million deaths and contributed to nearly five million overall. It’s a crisis that impacts every aspect of modern medicine, from surgery to cancer care.\n\nThe challenge is related not only to strengthening innovation but also to ensuring sustainable and appropriate access to both existing and new antibiotics, which requires a concerted approach to addressing the many interconnected challenges.\n\nThis session will delve into perspectives on the critical need for developing new antibiotics to treat resistant infections, and explore the path forward for concrete solutions to improve the innovation outlook and patient access. It will also explore how to maintain this priority high on the upcoming G7/G20 agendas.\n \n\nHosts:\nCARB-X\nInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)\n\n\nChairs:\n\nDeepali Patel\nAMR Action Fund | Director of International Policy | United States of America\n \n\n\n\n\nSpeakers:\n\nKhumbize Kandodo Chiponda\nMinister of Health | Malawi\n \n \n\n\nJoël Denis\nPublic Health Agency of Canada (PHAC) | Centre for Vaccine and Therapeutic Readiness | Director General | Canada\n \n \n\n\nDr. David Reddy\nInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Director-General | Switzerland\n \n \n\n\nDr. Stefan Hagel\nJena University Hospital | Assistant Medical Director | Germany\n \n \n\n\nDr. Tamas Andras Koncz\nPfizer | Accord Chief Medical Officer (CMO) | Germany\n \n \n\n\nLaurent Muschel\nEuropean Commission | Health Emergency Preparedness and Response (HERA) | Acting Director-General\n \n \n\n\nProf. Dr. Kevin Outterson\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) | Executive Director | United States of America\n \n \n\n\nFlorence Séjourné\nAUROBAC THERAPEUTICS | CEO | France\n \n \n\n\nNour Shamas\nWorld Health Organization (WHO) | AMR Survivors Taskforce Member & Antimicrobial Stewardship Consultant\n\n\n X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

PD 10 – Driving Action: Innovation and Access for a Resilient Response Against AMR


Exploring Future Scenarios and Shaping Better Solutions


Oct. 14, 2024, CEST: 02:00 PM - 03:30 PM / UTC: 12:00 PM - 01:30 PM



 


Digital Session: https://www.youtube.com/watch?v=_NqZhqOVU68


 



Panel Discussion (PD 10) - Europe


2024 is a significant year for addressing the urgency of Antimicrobial Resistance (AMR), which requires a broad, multi-stakeholder approach. Alarming statistics underpin the need for prompt action. In 2019, AMR was responsible for 1.27 million deaths and contributed to nearly five million overall. It’s a crisis that impacts every aspect of modern medicine, from surgery to cancer care.

The challenge is related not only to strengthening innovation but also to ensuring sustainable and appropriate access to both existing and new antibiotics, which requires a concerted approach to addressing the many interconnected challenges.

This session will delve into perspectives on the critical need for developing new antibiotics to treat resistant infections, and explore the path forward for concrete solutions to improve the innovation outlook and patient access. It will also explore how to maintain this priority high on the upcoming G7/G20 agendas.


 



Hosts:


CARB-X

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)



Chairs:



Deepali Patel

AMR Action Fund | Director of International Policy | United States of America


 






Speakers:

Khumbize Kandodo Chiponda

Minister of Health | Malawi


 


 




Joël Denis

Public Health Agency of Canada (PHAC) | Centre for Vaccine and Therapeutic Readiness | Director General | Canada


 


 




Dr. David Reddy

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Director-General | Switzerland


 


 




Dr. Stefan Hagel

Jena University Hospital | Assistant Medical Director | Germany


 


 




Dr. Tamas Andras Koncz

Pfizer | Accord Chief Medical Officer (CMO) | Germany


 


 




Laurent Muschel

European Commission | Health Emergency Preparedness and Response (HERA) | Acting Director-General


 


 




Prof. Dr. Kevin Outterson

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) | Executive Director | United States of America


 


 




Florence Séjourné

AUROBAC THERAPEUTICS | CEO | France


 


 




Nour Shamas

World Health Organization (WHO) | AMR Survivors Taskforce Member & Antimicrobial Stewardship Consultant




\n\n\n LOCATION: END:VEVENT END:VCALENDAR